NASDAQ:HSKA Heska (HSKA) Stock Forecast, Price & News $119.84 -0.01 (-0.01%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$119.82▼$119.8650-Day Range$92.52▼$119.8552-Week Range$57.83▼$119.90Volume374,623 shsAverage Volume230,295 shsMarket Capitalization$1.31 billionP/E RatioN/ADividend YieldN/APrice Target$137.25 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Heska MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside14.5% Upside$137.25 Price TargetShort InterestBearish10.55% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.82Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth220.00%From $0.45 to $1.44 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.85 out of 5 starsMedical Sector755th out of 983 stocksDiagnostic Substances Industry10th out of 15 stocks 2.3 Analyst's Opinion Consensus RatingHeska has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $137.25, Heska has a forecasted upside of 14.5% from its current price of $119.84.Amount of Analyst CoverageHeska has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted10.55% of the float of Heska has been sold short.Short Interest Ratio / Days to CoverHeska has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in Heska has recently increased by 24.59%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHeska does not currently pay a dividend.Dividend GrowthHeska does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HSKA. Previous Next 2.7 News and Social Media Coverage News SentimentHeska has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Heska this week, compared to 2 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Heska insiders have not sold or bought any company stock.Percentage Held by Insiders12.30% of the stock of Heska is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions99.01% of the stock of Heska is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Heska are expected to grow by 220.00% in the coming year, from $0.45 to $1.44 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Heska is -62.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Heska is -62.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHeska has a P/B Ratio of 3.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Heska (NASDAQ:HSKA) StockHeska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.Read More Receive HSKA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter. Email Address HSKA Stock News HeadlinesJune 2, 2023 | americanbankingnews.comHeska (NASDAQ:HSKA) Coverage Initiated at StockNews.comMay 24, 2023 | americanbankingnews.comHeska (NASDAQ:HSKA) Receives New Coverage from Analysts at StockNews.comJune 3, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 19, 2023 | msn.comHeska Earnings Perspective: Return On Capital EmployedMay 16, 2023 | americanbankingnews.comHeska (NASDAQ:HSKA) Now Covered by Analysts at StockNews.comMay 11, 2023 | businesswire.comHESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska ...May 9, 2023 | finance.yahoo.comStrong Fourth Quarter Results Supported Heska Corporation (HSKA) in Q1May 5, 2023 | finance.yahoo.comHeska (HSKA) Q1 Earnings and Revenues Lag EstimatesJune 3, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.May 5, 2023 | finance.yahoo.comHeska Corporation Reports First Quarter 2023 ResultsApril 21, 2023 | finance.yahoo.comHeska Announces Annual Meeting of Stockholders on May 3, 2023April 6, 2023 | americanbankingnews.comHeska (NASDAQ:HSKA) Sees Large Volume Increase on Analyst UpgradeApril 6, 2023 | americanbankingnews.comHeska (NASDAQ:HSKA) Downgraded by Alliance Global PartnersApril 6, 2023 | americanbankingnews.comMorgan Stanley Raises Heska (NASDAQ:HSKA) Price Target to $120.00April 5, 2023 | americanbankingnews.comMorgan Stanley Upgrades Heska (NASDAQ:HSKA) to Equal WeightApril 4, 2023 | finance.yahoo.comThe three-year returns have been strong for Heska (NASDAQ:HSKA) shareholders despite underlying losses increasingApril 3, 2023 | finance.yahoo.comWhy Heska Stock Is On Fire TodayApril 3, 2023 | finance.yahoo.comMars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty SolutionsMarch 1, 2023 | finance.yahoo.comHeska (HSKA) Q4 Earnings and Revenues Surpass EstimatesMarch 1, 2023 | finance.yahoo.comHeska Full Year 2022 Earnings: EPS Misses ExpectationsMarch 1, 2023 | finance.yahoo.comAt US$81.43, Is It Time To Put Heska Corporation (NASDAQ:HSKA) On Your Watch List?February 28, 2023 | finance.yahoo.comHeska Corporation Reports Fourth Quarter and Full Year 2022 ResultsFebruary 23, 2023 | finance.yahoo.comHeska to Present at Three Upcoming Institutional Investor ConferencesFebruary 13, 2023 | finance.yahoo.comHeska (HSKA) Moves to Buy: Rationale Behind the UpgradeFebruary 8, 2023 | finance.yahoo.comHeska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023January 18, 2023 | finance.yahoo.comIs There An Opportunity With Heska Corporation's (NASDAQ:HSKA) 50% Undervaluation?January 12, 2023 | gurufocus.comHeska Corp's CEO Loads Up on Shares After 70% NosediveSee More Headlines HSKA Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSKA Company Calendar Last Earnings11/04/2021Today6/03/2023Next Earnings (Estimated)8/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HSKA CUSIPN/A CIK1038133 Webwww.heska.com Phone(970) 493-7272Fax970-619-3003Employees655Year FoundedN/APrice Target and Rating Average Stock Price Forecast$137.25 High Stock Price Forecast$150.00 Low Stock Price Forecast$120.00 Forecasted Upside/Downside+14.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.93) Trailing P/E RatioN/A Forward P/E Ratio266.31 P/E GrowthN/ANet Income$-19,890,000.00 Net Margins-7.86% Pretax Margin-7.91% Return on Equity0.94% Return on Assets0.67% Debt Debt-to-Equity Ratio0.23 Current Ratio5.64 Quick Ratio4.12 Sales & Book Value Annual Sales$257.31 million Price / Sales5.08 Cash Flow$1.69 per share Price / Cash Flow70.83 Book Value$38.27 per share Price / Book3.13Miscellaneous Outstanding Shares10,910,000Free Float9,572,000Market Cap$1.31 billion OptionableNot Optionable Beta1.58 Key ExecutivesKevin S. WilsonPresident, Chief Executive Officer & DirectorCatherine I. GrassmanChief Financial Officer & Executive Vice PresidentGlenn R. FrankVice President-Research & DevelopmentSteven M. EylChief Commercial Officer & Executive VPEleanor F. BakerExecutive Vice President & Managing DirectorKey CompetitorsCelldex TherapeuticsNASDAQ:CLDXMyriad GeneticsNASDAQ:MYGNIntellia TherapeuticsNASDAQ:NTLANeogenNASDAQ:NEOGU.S. Physical TherapyNYSE:USPHView All CompetitorsInsiders & InstitutionsProShare Advisors LLCBought 23,572 shares on 5/26/2023Ownership: 0.216%Ameriprise Financial Inc.Bought 58,268 shares on 5/22/2023Ownership: 5.292%New York State Common Retirement FundBought 19,427 shares on 5/18/2023Ownership: 0.245%Thrivent Financial for LutheransSold 353 shares on 5/17/2023Ownership: 0.092%Meros Investment Management LPSold 302 shares on 5/16/2023Ownership: 0.437%View All Insider TransactionsView All Institutional Transactions HSKA Stock - Frequently Asked Questions Should I buy or sell Heska stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Heska in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HSKA shares. View HSKA analyst ratings or view top-rated stocks. What is Heska's stock price forecast for 2023? 4 brokers have issued 1-year price targets for Heska's stock. Their HSKA share price forecasts range from $120.00 to $150.00. On average, they predict the company's stock price to reach $137.25 in the next year. This suggests a possible upside of 14.5% from the stock's current price. View analysts price targets for HSKA or view top-rated stocks among Wall Street analysts. How have HSKA shares performed in 2023? Heska's stock was trading at $62.16 on January 1st, 2023. Since then, HSKA stock has increased by 92.8% and is now trading at $119.84. View the best growth stocks for 2023 here. Are investors shorting Heska? Heska saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,060,000 shares, an increase of 24.6% from the April 30th total of 850,800 shares. Based on an average daily volume of 266,700 shares, the short-interest ratio is currently 4.0 days. Currently, 10.6% of the shares of the stock are sold short. View Heska's Short Interest. When is Heska's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023. View our HSKA earnings forecast. How were Heska's earnings last quarter? Heska Co. (NASDAQ:HSKA) announced its quarterly earnings data on Thursday, November, 4th. The medical research company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by $0.23. The medical research company had revenue of $60.24 million for the quarter, compared to analysts' expectations of $63.80 million. Heska had a positive trailing twelve-month return on equity of 0.94% and a negative net margin of 7.86%. The company's revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.25) EPS. What ETFs hold Heska's stock? ETFs with the largest weight of Heska (NASDAQ:HSKA) stock in their portfolio include MFAM Small-Cap Growth ETF (MFMS), Motley Fool Small-Cap Growth ETF (TMFS), ProShares Pet Care ETF (PAWZ), SPDR S&P Health Care Equipment ETF (XHE), Motley Fool Mid-Cap Growth ETF (TMFM), Invesco S&P SmallCap Health Care ETF (PSCH), Royce Quant Small-Cap Quality Value ETF (SQLV) and Principal Healthcare Innovators ETF (BTEC). What is Kevin S. Wilson's approval rating as Heska's CEO? 5 employees have rated Heska Chief Executive Officer Kevin S. Wilson on Glassdoor.com. Kevin S. Wilson has an approval rating of 57% among the company's employees. This puts Kevin S. Wilson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Heska own? Based on aggregate information from My MarketBeat watchlists, some companies that other Heska investors own include Gilead Sciences (GILD), Exxon Mobil (XOM), Netflix (NFLX), Biogen (BIIB), AbbVie (ABBV), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Exelixis (EXEL) and Merck & Co., Inc. (MRK). What is Heska's stock symbol? Heska trades on the NASDAQ under the ticker symbol "HSKA." Who are Heska's major shareholders? Heska's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (17.20%), Fred Alger Management LLC (7.59%), Ameriprise Financial Inc. (5.29%), State Street Corp (3.98%), abrdn plc (3.35%) and Riverbridge Partners LLC (2.83%). Insiders that own company stock include Bonnie J Trowbridge, Catherine Grassman, Jason D Aroesty, Kevin S Wilson, Nancy Wisnewski and Sharon J Larson. View institutional ownership trends. How do I buy shares of Heska? Shares of HSKA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Heska's stock price today? One share of HSKA stock can currently be purchased for approximately $119.84. How much money does Heska make? Heska (NASDAQ:HSKA) has a market capitalization of $1.31 billion and generates $257.31 million in revenue each year. The medical research company earns $-19,890,000.00 in net income (profit) each year or ($1.93) on an earnings per share basis. How many employees does Heska have? The company employs 655 workers across the globe. How can I contact Heska? Heska's mailing address is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. The official website for the company is www.heska.com. The medical research company can be reached via phone at (970) 493-7272, via email at investorrelations@heska.com, or via fax at 970-619-3003. This page (NASDAQ:HSKA) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heska Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.